quinapril has been researched along with Carditis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aizawa, Y; Fuse, K; Hasegawa, G; Juan, W; Kato, K; Kodama, M; Ma, M; Naito, M; Nakazawa, M; Wahed, MI; Watanabe, K; Yamamoto, T | 1 |
| Aizawa, Y; Fuse, K; Hanawa, H; Inoue, M; Kodama, M; Kouda, T; Ma, M; Nakazawa, M; Ohta, Y; Sekiguchi, T; Wahed, MI; Watanabe, K; Yamamoto, T; Yoshida, Y | 1 |
2 other study(ies) available for quinapril and Carditis
| Article | Year |
|---|---|
Quinapril inhibits progression of heart failure and fibrosis in rats with dilated cardiomyopathy after myocarditis.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cardiomyopathy, Dilated; Collagen Type III; Dose-Response Relationship, Drug; Fibronectins; Fibrosis; Gene Expression; Heart Function Tests; Male; Myocarditis; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Survival Rate; Tetrahydroisoquinolines; Time Factors; Transforming Growth Factor beta; Transforming Growth Factor beta1; Ventricular Function, Left; Ventricular Pressure | 2003 |
Inhibition of progression of heart failure and expression of TGF-beta 1 mRNA in rats with heart failure by the ACE inhibitor quinapril.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Heart Failure; Isoquinolines; Male; Myocarditis; Quinapril; Rats; Rats, Inbred Lew; RNA, Messenger; Tetrahydroisoquinolines; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |